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ABSTRACT 
 
Influence of Maternal Plane of Nutrition and Arginine Supplementation on Mares and 
Their Foals: Glucose and Insulin Dynamics. (August 2012) 
Andrea Estelle Hanson, B.S., Texas A&M University 
Chair of Advisory Committee: Dr. Josie Coverdale 
 
 Thirty-two Quarter horse mares (468 to 668 kg BW; 3 to 19 yr) were utilized in a 
randomized complete block design.  Animals were blocked by expected foaling date and 
randomly assigned to treatments within block.  Treatments began 110 d prior to expected 
foaling date and were arranged as a 2 x 2 factorial consisting of two planes of nutrition, 
moderate (Mod; 0.5% BW as fed grain/d) or high (High; 1% BW as fed grain/d) and two 
levels of L-arginine supplementation, 0.21 g/kg BW/d (Arg) or no supplemental Arg 
(Con; L‐alanine to maintain isonitrogenous diets). Mares were housed by block, allowed 
ad libitum access to water and coastal bermudagrass (Cynodon dactylon) hay, and fed 
commercial grain twice daily in individual stalls.  
A modified frequent sampling i.v. glucose tolerance test (FSIGT) was performed 
on mares during the 11
th
 month gestation and on foals at 5 and 30 d of age.  Jugular 
catheters were placed 1 h before FSIGT, and horses were allowed ad libitum access to 
bermudagrass hay and water throughout. After a baseline plasma sample was collected, a 
glucose bolus of 0.3 g/kg BW was administered. Blood samples were collected at 1, 2, 3, 
4, 5, 6, 7, 8, 10, 12, 14, 16, and 19 min.  At minute 20, an insulin bolus of 30 mU/kg BW 
was administered. Blood samples continued to be collected at 22, 23, 24, 25, 27, 30, 35, 
iv 
40, 50, 60, 70, 80, 90, 100, 120, 150, and 180 min.  Samples were placed into tubes 
containing sodium heparin, immediately placed on ice, and centrifuged within 20 min. 
Plasma was then collected, placed in microtubes and frozen at -20
o
C for later analysis.   
Glucose concentrations were analyzed using a colorimetric assay and insulin 
concentrations determined using a commercial RIA kit. There was no influence of 
dietary treatment on mare glucose area under the curve (AUCg) or peak glucose (PG) 
and insulin (PI) concentrations (P ≥ 0.55). Mare insulin area under the curve (AUCi) 
tended to be influenced by the interaction between nutritional plane and ARG 
supplementation (P ≤ 0.06) with HighCon mares having greater AUCi than ModCon (P 
≤ 0.05), and HighCon mares having greater AUCi than mares fed HighArg (P ≤ 0.05).  
Foal AUCg, AUCi, and PI were not influenced by maternal diet. However, PG 
concentration in foals tended to be influenced by mare AA supplementation with foals 
from Con mares having higher concentrations compared to Arg (P ≤ 0.09) An influence 
of age was observed on foal AUCg and AUCi.  Foal AUCg was greater at 5 d compared 
to 30 d (P ≤ 0.003).  Foal AUCi tended to be greater at 30 d compared to 5 d (P ≤ 0.08). 
Data suggest maternal plane of nutrition and arginine supplementation can alter mare 
and foal glucose and insulin dynamics. 
 
 
 
 
 
 
v 
DEDICATION 
 
I would like to dedicate this thesis to my friends and family who have provided 
me with encouragement, guidance, and wisdom. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
vi 
ACKNOWLEDGEMENTS 
 
A special thank you to my committee chair, Dr. Josie Coverdale for her excellent 
guidance and support throughout my graduate career.  I would also like to thank my 
committee members Dr. Tryon Wickersham and Dr. David Hood.  I was lucky to have 
such an amazing group of mentors who took interest in my learning as a student both in 
the classroom and in the field.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
vii 
TABLE OF CONTENTS 
 
Page         
ABSTRACT……………………………………………………………………… iii 
DEDICATION………………………………………………………………….... v 
ACKNOWLEDGEMENTS……………………………………………………....   vi 
TABLE OF CONTENTS………………………………………………………… vii 
LIST OF FIGURES……………………………………………………………… ix 
LIST OF TABLES………………………………………………………………. x 
CHAPTER 
 I INTRODUCTION AND REVIEW OF LITERATURE……….. 1 
    Introduction……………………………………………... 1 
   Obesity………………………………………………….. 1 
   Insulin………………………………………………….... 2 
   Maternal Metabolism……………………………………. 6 
   Arginine Supplementation………………………………. 12 
   Conclusion………………………………………………. 16 
 
 II MATERIALS AND METHODS……………………………….. 18 
 
   Animals and Treatments...……………………………….. 18 
   Mare Performance Measurements……………………….. 19 
   Frequent Sampling IV Glucose Tolerance Test (FSIGT)… 20 
   Glucose and Insulin Analysis…………………………….. 21 
   Statistical Analysis……………………………………….. 23 
 
 III RESULTS AND DISCUSSION…………………………………. 24 
  
   Mare Measurements……………………………………… 24 
   Mare Glucose and Insulin………………………………… 24 
   Foal Glucose and Insulin…………………………………. 28 
 
 IV CONCLUSIONS…………………………………………………. 37 
 
LITERATURE CITED…………………………………………………………… 38 
 
viii 
              Page 
 
VITA………………………………………………………………………….........  45 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ix 
LIST OF FIGURES 
 
 
FIGURE             Page 
 
1 Roles of arginine, NO, and polyamines in fetal growth…………….    12 
 
2 Arginine metabolism………………………………………………..    13 
 
3 Effects of nutrition and ARG supplementation on mare glucose  
and insulin during modified FSIGT in the last third of pregnancy….    26 
 
4 Effects of maternal nutrition and ARG supplementation on  
foal d 5 glucose and insulin during modified FSIGT………………...   30 
 
5 Effects of maternal nutrition and ARG supplementation on 
foal d 30 glucose and insulin during modified FSIGT……………….   32 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
x 
LIST OF TABLES 
 
 
TABLE             Page 
              
1 Energy and nutrient composition of concentrate and hay (DM basis)  
fed to mares…………………………………………………………..   19 
 
2 Effect of plane of nutrition and arginine1 (ARG) supplementation on 
peak glucose (PG), peak insulin (PI), glucose area under the curve 
(AUCg), and  insulin area under the curve (AUCi)
2
 performed during 
FSIGT
3
 in the last third of equine gestation…………………………..   25 
 
3 Effect of plane of nutrition and arginine1 (ARG) supplementation on  
peak glucose (PG), peak insulin (PI), glucose area under the curve 
(AUCg), and  insulin area under the curve (AUCi)
2
 performed during 
FSIGT
3
 on foals at d 5 and d 30 of age……………………………….   29 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
CHAPTER I 
INTRODUCTION AND REVIEW OF LITERATURE 
Introduction 
 Maternal metabolism effect on the developing fetus is an area of interest 
in many species, including the horse. Until 350 years ago, a horse’s diet consisted 
primarily of forage material, but as pasture development improved and animal workload 
increased, grain supplementation became a common management practice (Kronfeld and 
Harris, 2003). Feeding cereal grains rich in non-structural carbohydrates (NSC) can 
provide greater quantities of digestible energy (DE) compared to forage.  Increased 
dietary DE can enhance growth and performance of an animal, but over feeding grains 
can potentially induce or increase obesity, or lead to other metabolic disorders (Geor, 
2008).  
Obesity  
Equine obesity is a growing concern as it has been estimated that nearly 50% of 
the equine population in Western civilization is obese (Sillence et al., 2002).  Obesity 
may be defined as an excess of body fat significant enough to cause impairment to health 
(Dugdale et al., 2010).  In humans, body mass index determines obesity.  Although there 
is not a universal definition of obesity in the horse, Henneke et al. (1983) developed a 
body condition score (BCS) system as an evaluation tool for owners, veterinarians, and 
nutritionists to assign a numerical value to the amount of fat observed on an animal.  
BCS ranges from 1 to 9, with 1 representing an emaciated animal and 9 representing a 
morbidly obese animal.  Each number is assigned based on appearance and physical  
____________  
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Palpation of 6 distinct locations on the body: over the ribs, along the neck, behind the 
shoulder, around the withers, above the tail head, and down the back.  Ideal BCS 
depends upon use of the animal with a score of 5 being ideal for maintenance or 
performance horses, and 6 being ideal for reproductive performance.  Animals with a 
BCS of 7 are overweight and greater than 8 is obese (Henneke et al., 1983).   Excess 
body fat and obesity in the horse can eventually lead to other disorders such as 
hypertension, laminitis, equine metabolic syndrome, and insulin resistance (Kronfeld, 
2003). 
Insulin 
Glucose metabolism and insulin response.  Equine digestive systems are known 
primarily for hindgut fermenting capabilities which converts forage structural 
carbohydrates into volatile fatty acids (VFA) to meet energy requirements.  However, 
equids also have capacity for small intestine digestion of NSC, which is metabolically 
more efficient in the utilization of energy (Parker, 2008).  During foregut enzymatic 
digestion, soluble carbohydrates are hydrolyzed into glucose. Glucose is then transported 
out of the intestinal lumen via secondary active transport sodium and glucose 
transporters (SGLT), located within the brushy border, and into the blood stream via 
glucose transporter (GLUT), GLUT 2.  Glucose is used as an energy source for all 
metabolic processes of the body (Sherwood, 2010).  
Research has found approximately 50% of glucose use occurs in the brain, while 
the splanchnic area disposes of about 25%.  Both tissues are considered insulin-
independent tissue, meaning there is no reliance on hormones for absorption of glucose 
out of the blood stream and into tissue.  The remaining 25% of glucose is dependent on 
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the hormone insulin for absorption (DeFronzo, 1988).  Under normal physiological 
conditions, an increase in circulating blood glucose levels signals conversion of pro-
insulin into an active peptide, insulin, through excitation coupling.  Insulin is produced 
in the -cells of the pancreas located within the islets of Langerhans.  Insulin is then 
secreted along with its residual connecting peptide, C-peptide, into the blood stream 
(Horwitz et al., 1975).  Human, porcine, and equine insulin differ by only two amino 
acids (Kim et al., 2006).  Because of the close similarities in composition, exogenous 
human and porcine insulin is commonly used in equine research.  Furthermore, studies 
have shown porcine and human insulin elicits similar response in humans (Greene et al., 
1983).  Metabolically, the role of insulin is to maintain whole body glucose homeostasis 
as it promotes glucose transport, metabolism, and uptake into tissue.   
Glucose is transported through glucose transporters (GLUT) from the blood into 
the surrounding tissue.  While there are fourteen known forms of GLUT, GLUT 4 is the 
primary transporter of glucose into insulin dependent tissues such as muscle and adipose 
tissue.  GLUT 4 is located intracellular and only translocates to the plasma membrane in 
response to insulin binding (Sherwood, 2010).  As insulin binds to transmembrane 
insulin receptors located on the plasma membrane, intracellular tyrosine kinase is 
activated.  As tyrosine kinase is quickly phosphorylated at the intracellular portion of the 
receptor, the phosphatidylinositol 3-kinase (PI-3K) pathway is activated.  This results in 
an insulin stimulated intracellular signaling pathway ultimately resulting in the 
translocation of intracellular glucose transporter GLUT 4 to the plasma membrane. 
GLUT 4 acts as a channel for glucose to enter the cell.  Once inside the cell, glucose is 
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quickly phosphorylated into glucose-6-phosphate, preventing glucose from exiting the 
cell (Shepherd and Kahn, 1999).  
In addition, to the activation of GLUT 4, insulin stimulates glycogen synthesis in 
skeletal muscle and liver tissue, which acts as a storage molecule for excess circulating 
blood glucose and down regulates gluconeogenisis in the liver (Shepherd and Kahn, 
1999; Kronfeld et al., 2005).  Insulin also stimulates nitric oxide (NO) production in the 
vascular endothelium, which releases a vasodilator through PI-3K pathway.  
Simultaneously, insulin activates the release of endothelin-1 (ET-1) which is a 
vasoconstrictor released through the mitogen-activated protein kinase (MAPK) pathway 
(Kim et al., 2006).   Furthermore, insulin inhibits the hydrolysis of triglycerides and 
increases adipose storage by preventing the breakdown of triglycerides in adipose tissue 
through inhibition of intracellular lipase.  Insulin also stimulates the conversion of free 
fatty acids into fatty tissue and synthesis of glycerol (Frank et al., 2006; Sherwood, 
2010).   
Insulin resistance and sensitivity.  Abnormal cellular response to circulating 
insulin can be generally described as insulin resistance (IR).  More specifically, insulin 
resistance can be associated with a decreased responsiveness, decreased sensitivity, or a 
decrease of both responsiveness and sensitivity of tissue to circulating insulin.  
Decreased insulin responsiveness is defined as a state where the maximum cellular 
response to normal amounts of insulin is decreased.  Decreased sensitivity to insulin (SI) 
is defined as a state where maximum cellular response to insulin remains unchanged, 
while greater amounts of the hormone are required to elicit a normal response (Kahn, 
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1978). Because of the similarities, equine literature commonly uses the terms IR and SI 
interchangeably.   
In human medicine, altered insulin response is defined as either type 1 or type 2 
diabetes mellitus.  Patients with type 1 diabetes fail to produce sufficient amounts of 
endogenous pancreatic insulin in response to elevated blood glucose.  Characterized by 
continuously high levels of glucose in the blood stream, exogenous insulin must be 
administered for proper glucose up take into tissue.  This type of impaired insulin 
production is uncommon in horses, and usually associated with gestational defects or 
injury to the pancreas (Roberts and Hill, 1973).  In type 2 diabetes, adipose tissue, 
skeletal muscle, and liver cells fail to respond to insulin signaling.  Type 2 diabetes is 
also coupled with -cell exhaustion in humans (Stumvoll et al., 2005). In the horse, type 
2 diabetes mellitus is rare, as compensation for reduced insulin response is overcome by 
an increase in pancreatic -cells insulin production (Kronfeld et al., 2005).   
Dysfunction in human cellular response is thought to occur at the PI-3K pathway 
which is the pathway associated with GLUT 4 translocation, while the MAPK pathway 
remains intact (Shepherd and Kahn, 1999; Kahn and Flier, 2000).  In all animals, IR can 
be physiologically associated with starvation or pregnancy, or pathologically associated 
with obesity (Rijnen and van der Kolk, 2003).  
Obesity, insulin resistance, and diet.  Equine research has found a link between 
obesity, insulin resistance and diet.  Hoffman et al. (2003a) used a minimal model to 
estimate glucose effectiveness and insulin sensitivity in obese and non-obese horses 
adapted to diets with varying NSC content.  The minimal model has been primarily used 
in human diabetes research and distinguishes glucose disposal independent of insulin.  It 
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is important to note, in this study BCS of each horse was maintained at a range of 5 to 8, 
with 5 to 5.9 labeled as non-obese, 6 to 6.9 as moderately obese, and 7 to 9 as obese.  
Animals were adapted to a forage only diet during period 1.  During period 2, animals 
were divided into two separate groups with one group fed a diet high in starch and sugar 
and the other fed an isocaloric diet high in fat and fiber.  Period 3 completed the cross 
over design.  Modified frequent sampling i.v. glucose tolerance tests (FSIGT) were 
performed after adaptation to each of the three diets.  This study was instrumental in 
demonstrating FSIGT as a useful tool in evaluating glucose and insulin dynamics in the 
horse.  Results indicated obese insulin sensitivity was 80% lower than non-obese with 
decreased glucose tolerance.  Furthermore, obese horses secreted larger quantities of 
endogenous insulin in response to blood glucose as compared to non-obese.  Results 
indicate that horses fed grain meals rich in starch and sugar (SS) have a greater risk of 
developing insulin resistance.  A decrease in -cell production of endogenous insulin in 
response to exogenous glucose was seen in horses fed SS.  This suggests animals 
became progressively less sensitive to the elevated blood glucose levels and required 
greater concentrations prior to pancreatic insulin secretion (Hoffman et al. 2003a).  
Similar studies support the conclusion that feeding diets high in NSC alters insulin 
response and contributes to the development of IR (Kronfeld et al., 2005).  Additional 
data from Pratt et al. (2005) indicated a 30% decrease in insulin mediated glucose 
disposal and an increase in insulin production in horses fed high NSC diets for 6 wk.  
Maternal Metabolism 
Research suggests variations in maternal diet can alter physiological adaptations 
of equine metabolism during pregnancy.  Hoffman et al. (2003b) evaluated the effect of 
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a high starch and sugar diet (SS) based on corn grain and molasses compared to a corn 
oil supplemented fat and fiber diet (FF), on pregnant mare metabolism.  Although this 
study found mares fed SS had lower sensitivity to oral glucose and faster glucose 
removal, it demonstrated the ability to alter equine maternal metabolism through diet.  
More recent research by Winsco et al. (2011) studied the effects of DE manipulation on 
mare metabolism looking specifically at the glucose and insulin response.  During late 
pregnancy, mares were adapted to either a forage and grain diet (FG) or forage only diet 
(F).  During the 11
th
 month of gestation, FSIGT were performed on the pregnant mares.  
Results concluded FG mares had greater circulating blood glucose and insulin 
concentrations, suggesting increased insulin resistance in FG mares.  Metabolic 
adaptation occurred resulting in a decrease of glucose and insulin response in FG diets.   
Natural metabolic changes occur during pregnancy, which prepare an animal for 
the increase in energy requirements for placental and fetal growth and development.  
These changes ensure a continuous supply of nutrients will reach the developing 
offspring independent of diet.  Human research has considered late pregnancy a 
diabetogenic state because of a 50% decrease in insulin mediated glucose disposal in 
maternal metabolism (Zavalza-Gomez et al., 2008).  Equine research has found similar 
characteristics during late stage pregnancy including an increased production of insulin 
in response to circulating glucose.  Increased insulin secretion has been coupled with a 
decrease of insulin sensitivity in maternal metabolism, resulting in significantly slower 
glucose removal (Hoffman et al., 2003b; George et al., 2011).  These normal adaptations 
to pregnancy are characterized by changes in pancreatic -cell function, which 
contribute to pregnancy induced insulin resistance (Fowden et al., 1984).   
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Diet effect on intrauterine environment.  Adaptations to maternal nutrition can 
alter maternal metabolism, and eventually, impact fetal growth and development through 
influence of the intrauterine environment.  The intrauterine environment directly 
influences the structure, physiology, and metabolism of a developing fetus.  The fetus 
can adapt to changes in the environment, a phenomenon known as “fetal programming” 
(Barker and Clark, 1997), but these adaptations may have immediate or life-long 
implications on the developing offspring (Wu et al., 2004). 
Under normal physiological conditions, transfer of nutrients from maternal blood 
to fetal blood occurs across a thin placental barrier.  Horses have a diffuse, 
microcotyledonous placenta, and makes full contact with the uterine wall, which 
increases fetal nutrient supply.  Ovine placenta is a similar epithelochorial structure to 
the equine placenta.  Some substance such as oxygen, carbon dioxide, water and 
electrolytes easily diffuse across the membrane.  Amino acids are transferred from 
mother to fetus by a secondary active transport system (Wooding and Fowden, 2006). 
Glucose is readily transported between maternal and fetal blood, but does require 
the establishment of a concentration gradient (Hay et al., 1984; Sherwood, 2010).  This 
concentration gradient permits the diffusion of glucose through GLUT 1 transport 
proteins (Smith et al., 1992).  The placenta utilizes a large portion of the glucose supply 
as research in sheep during late term pregnancy has shown the placenta accounts for 50-
75% of uterine glucose uptake.  This creates hypoglycemia in the fetus and contributes 
to an increase in the overall glucose concentration gradient between maternal and fetal 
blood (Hay, 1995).   
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The intrauterine programming of fetal metabolism occurs during late gestation as 
pancreatic insulin production begins to respond to available glucose (Fowden and Hill, 
2001; Fowden et al., 2005).  Glucose intolerance and other metabolic disorders can be 
induced during this period of growth.  In the rat, maternal nutrient manipulation during 
the last 7 d of gestation caused adult glucose intolerance in the offspring (Holeman et al., 
2003).  Increased fetal β-cell insulin secretion was observed during late gestation in the 
horse (Fowden et al., 2005), and continued to increase past parturition (Holdstock et al, 
2004).  Winsco et al. (2011) indicated programming of foal metabolism can occur 
through maternal dietary manipulation.  Grain supplementation in mares during the last 
third of pregnancy was seen to decrease insulin sensitivity and alter glucose clearance in 
the offspring.   
The function of insulin in the fetus is to maintain optimal growth, and alter 
glucose and protein metabolism (Brown and Hay, 2006).  In the event of continuous 
hyperglycemia, the fetal pancreas down regulates -cell production of insulin in sheep 
(Jackson et al., 1993) and decreases GLUT 4 expression potentially limiting fetal growth 
and development (Carver et al. 1995).  In contrast, human research indicated a greater 
fetal pancreatic release of insulin in response to elevated glucose levels from diabetic 
mothers (Baird and Farquhar, 1962). During maternal hypoglycemia, glucose utilization 
by the placenta decreases. This decrease in placental glucose supply will result in a 
decrease in placental weight. Changes in maternal glucose supply results in significant 
adaptations to placental growth and metabolism (Hay, 1995). 
Fetal hyperinsulinaemia, which can be induced by maternal diabetes, increases 
nutrient availability, increases lipid content (Stevens et al., 1990) and stimulates insulin 
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growth factors in the fetus (Fowden, 1992). This can cause abnormalities in fetal growth.  
Ovine research has determined hyperinsulinemia increases the amino acid and nitrogen 
utilization rates of the fetus independent of glucose (Thureen et al., 2000).   
Disturbances, that alter development and growth of either the placenta or fetus, 
result in intrauterine growth retardation (IUGR).  Influence of maternal nutrition is a 
contributing factor to IUGR and can cause such metabolic issues as insulin resistance,  
cell dysfunction, glucose intolerance, and obesity in the developing offspring (Barker 
and Clark, 1997).  In humans, twin pregnancies increase the risk of at least one of the 
infants developing IUGR, and the IUGR infant will have a higher risk of developing 
type 2 diabetes mellitus in later stages of life than the twin with normal intrauterine 
growth (Philips et al., 1994).  Early IUGR research looked specifically at the effects of 
maternal under nutrition on the intrauterine environment, but recent studies suggest both 
maternal under and over nutrition can induce IURG (Wu et al., 2004). 
In ovine research, maternal nutrient restriction during late pregnancy results in a 
reduction of placental and fetal growth.  Maternal over nutrition decreases placental 
weight, which directly decreases fetal growth and increases fetal mortality (Wallace et 
al., 1996; Wallace et al., 2002).  In human research, maternal over nutrition results in 
fetal growth restriction, increased risk of neonatal mortality, and increased obesity 
during childhood and later stages of life (Castro and Avina, 2002).  Minimal research in 
the horse has looked specifically at IUGR.  Winsco et al. (2011) indicated mare dietary 
manipulation does not result in premature delivery of low birth weight foals or a 
decrease in placental mass as observed in other species.  While indications of IUGR 
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were not observed in placenta or fetal weight, the effects of fetal programming were 
observed in the analysis of foal metabolism.   
Nitric oxide and placental angiogenesis.  Minimal knowledge exists about the 
specific mechanism of IUGR, but it has been associated with impaired NO production 
and deceased polyamine synthesis in the placenta.  Nitric oxide is a vasodilator, which 
plays an important role in the regulation of uteroplacental blood flow and nutrient 
transfer.  Polyamines regulate cell proliferation and differentiation in placental 
vasculature providing an optimal growth environment for the fetus (Bird et al., 2003; Wu 
et al., 2004).  
The placenta functions as the digestive system, respiratory system, and kidney 
for the developing offspring (Sherwood, 2010).  Therefore, placental angiogenesis and 
blood flow impact the transplacental exchange of nutrients and oxygen from mother to 
fetus, directly impacting development and growth (Reynolds and Redmer, 2001).  
Research in sheep has shown maternal placental vasculature develops steadily 
throughout gestation, while fetal placental vasculature develops rapidly during the last 
third of gestation in order to provide sufficient nutrients as the fetus increases in size 
(Stegeman, 1974).  Congruently, NO synthesis has been shown to increase during stages 
of greatest fetal development (Kwon et al., 2003).  Since NO and polyamines are both 
products of L-arginine (ARG) degradation (Figure 1), ARG could potentially be an 
important molecule in fetal development (Wu et al., 2006).  
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Figure 1.  Roles of arginine, NO, and polyamines in fetal growth (Wu et al., 2006) 
 
Arginine Supplementation 
Arginine: synthesis and degradation. L-arginine is classified as a basic, non-
essential, amino acid in adult humans, but has been shown to be conditionally essential 
for many young, growing, and pregnant animals (Milner et al., 1974; Gross et al., 1991; 
Rogers et al., 1970).  Endogenously, ARG can be synthesized in the liver via the urea 
cycle, but is rapidly broken down by the high activity of arginase. 
Enterocytes, absorptive epithelial cells in the small intestine, can synthesis L-
citrulline (CIT; Figure 2), which is a precursor of ARG.  In addition, glutamine, 
glutamate, and proline in the intestinal-renal axis contribute to the synthesis of both CIT 
and ARG through the pyrroline-5-carboxylate (P5C) synthethase and N-acetylglutamate 
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(NAG) pathways (Wu and Morris 1998; Flynn et al., 2002).  The metabolic pathways of 
arginine are illustrated in Figure 2. 
 
 
Figure 2. Arginine metabolism. ADC arginine decarboxylase, AGA agmatinase, 
AGTA arginine:glycine amidinotransferase, ASL argininocuvvinate lyase, ASS 
aspartate, AS argininosucinate, Asp aspartate, BH4  (6R)-5,6,7,8-tetrahydro-L-biopterin, 
CP carbamoylphosphate, CPS-1 carbamoylphosphate, synthetase-I (ammonia), DCAM 
decarboxylated S-adenosylmethionine, Glu glutamate, Gln glutamine, GDH glutamate 
dehydrogenase, GA guanidinoacetate, GMAT guanidinoacetate N-methyltransferase, 
CK creatine kinase, CR-P creatine-phosphate, -KG -ketogluterate, MTA 
methylthioadenosine, NAG N-acetylglutamate, NAGS N-acetylglutamate synthase, NO 
nitric oxide, NOS nitric oxide synthase, OAT ornithine aminotransferase, OCT ornithine 
carbamoyltransferase, ODC ornithine dearboxylase, PO proline oxidase, P5CD prroline-
5-carboxylate dehydrogenase, P5CR, prroline-5-carboxylate reductase, P5CS, prroline-
5-carboxylase synthase, PUT putrescine, SAM S-adenosylmethionine, SAMD S-
adenosylmethionine decarboxylase, SAHC S-adenosylhomocysteine, SPDS sermidine 
synthase. From Biomedicine and Pharmocotherapy (Fang et al., 2000). 
 
 
Although ARG synthesis can occur, dietary ARG is usually sufficient to sustain 
bodily functions, as it is abundant in plant based corn and soybean meal diets.  Transport 
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of ARG into cells occurs through System y+, which is a high affinity sodium 
independent transporter of basic amino acids (Flynn et al., 2002).  Once inside the cell, 
ARG catabolism occurs through multiple pathways and is degraded by multiple enzymes 
to include arginase (Arg), nitric-oxide synthase (NOS), arginine:glycine 
amidinotransferase, and ARG decarboxylase (Figure 2).   
Production of NO occurs as ARG is metabolized to CIT by NOS.  This occurs 
though one of the three NOS isoforms: endothelial (e)NOS, neuronal (n)NOS, or 
inductile (i)NOS.  Because the ARG degradation pathways are complex and involve 
multiple systems, ARG can have a significant impact on overall body health (Wu and 
Morris 1998; Hefler et al., 2001; Flynn et al., 2002; Wu et al., 2007; Wu et al., 2009).   
Arginine and obesity.  Using Zucker diabetic fatty (ZDF) rats genetically altered 
to exhibit hyperglycemia, dyslipedemia, insulin resistance, and 14ndothelial dysfunction, 
Fu et al. (2005) found ARG supplementation reduced fat mass, body weight, and 
epididymal adipose tissue.  A 25% decrease in fat mass was observed after a 10-wk 
treatment of ARG supplementation in the genetically obese rodents.  Serum samples 
revealed elevated NO production in supplemented animals, and adipose tissue had 
increased expression of ARG products and enzymes.  They determined ARG 
supplementation increased oxidation of both glucose and fatty acid in adipose tissue.   
Knockout mice deficient in eNOS and exhibiting inhibited NO production had 
higher body fat composition, reduced energy expenditure, increased weight gain, and 
increased insulin resistance compared to wild type mice with normal NO production.  It 
was also found peroxisome proliferator activated receptor  (PPAR ) coactivatior-1  
(PGC-1 ) is downregulated in the eNOS knockout mice (Nisoli et al., 2003).  The 
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PPAR  PGC-1  is a regulator of oxidative phosphorylation, mitochondrial biogenesis, 
and glucose/fatty acid metabolism.  It is activated by NO potentially produced during 
ARG degradation.  Under fasting conditions, the stimulation of PGC-1  has been shown 
to increase oxidation of energy substrates to produce glucose (Lehman et al., 2000; 
Liang and Ward, 2006).  In addition, PGC-1  has increased GLUT 4 activity and 
increased insulin sensitivity in animals with decreased insulin response (Michael et al., 
2001; Yoon et al., 2001).  
 Arginine effects on insulin.  As previously discussed, -cell function and insulin 
secretion in adult animals is controlled by circulating metabolites, such as glucose.  
Additional research reveals amino acids (AA), particularly ARG, can metabolically 
stimulate the release of glucagon and secretion of pancreatic insulin in humans and in 
other species (Fajans et al., 1967; Gerich et al., 1974; Fowden, 1980).  The pathway in 
which ARG stimulates the release of insulin differs from glucose as ARG stimulates the 
release by direct -cell membrane depolarization (Gresores et al., 1997; Thams and 
Capito, 2000), and can therefore, initiate a more rapid insulin release than the secondary 
pathway of glucose.  
Pancreatic sensitivity to ARG has also been documented in the pancreas of the 
developing human fetus (Milner et al., 1974).  Research in sheep has shown fetal insulin 
release actually responded more rapid to ARG than to glucose.  Fowden (1980) was able 
to compare insulin response to glucose and to ARG by utilizing an adrenaline infusion, 
which reduces basal insulin secretion and abolishes glucose mediated insulin release 
from pancreatic -cells.  While many of these studies directly infused the fetus with 
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ARG, the actually maternal-fetal transfer of ARG is slow and requires a significant 
concentration gradient (Gresores et al., 1997).  
Arginine effects on fetal development.  In addition to the ARG induced fetal 
insulin response, ARG supplementation and NO production can impact growth and 
development of a fetus.  Porcine ARG supplementation tends to increase live birth 
number and live birth weight of piglets as compared to animals without ARG 
supplementation (Mateo et al., 2007).  
Hefler et al. (2001) observed IUGR in eNOS-knockout mice.  Fetal mice were 
observed to demonstrate reduced fetal growth, reduced survival rate, and increased 
developmental abnormalities resulting from a decrease in NO production.  In humans, 
sampling of infants considered small for gestational age revealed a decrease in NO 
production as compared to infants of appropriate size (Hata et al., 1998).   It was also 
found premature humans exhibit ARG deficiency (Becker et al. 2000).  Furthermore, 
reduced placental blood flow due to impaired NO production was observed in over 
nourished sheep (Wallace et al., 2003).  Administration of ARG in IUGR sheep 
increased fetal growth (Lassala, 2008) and increased birth weight of IUGR humans 
(Xiao and Li, 2005).  While the role of arginine in NO production and IGUR has been 
demonstrated in several species, minimal research has focused on equine ARG 
supplementation.   
Conclusion 
 The medical implications of obesity and diet leading to metabolic disorders 
across species compounded with the effects of fetal programming have opened a wide 
range of potential experimental designs.  The common equine management practice of 
17 
feeding high starch grains has lead to an interest in the role maternal nutrition plays on 
mare metabolism as well as metabolic development of the foal.  Potential ways to 
mitigate negative effects such as arginine supplementation are of interest.  Therefore, the 
objectives of the current study were to determine the influence of maternal nutritional 
plane and ARG supplementation on mares and foals.  Mare performance, metabolism, 
foaling parameters, colostrum quality, passive immunity, and reproductive hormones 
were evaluated, in addition to foal metabolism and growth.  The following document 
focuses only on the objectives related mare and foal insulin and glucose dynamics. It is 
hypothesized that ARG supplementation will mitigate the negative effects of increased 
maternal nutrition on mare and foal insulin and glucose dynamics.   
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CHAPTER II 
MATERIALS AND METHODS 
All procedures were approved by the Texas A&M University Institutional 
Animal Care and Use Committee. 
Animals and Treatments 
Thirty-two pregnant Quarter horse mares (468 to 668 kg BW; 3 to 19 yr), on loan 
from a single farm, were pasture housed at the Texas A&M University Horse Center, 
and used in a randomized complete block design.  Mares were blocked by expected 
foaling date and randomly assigned to 1 of 4 dietary treatments within block.  
Treatments were arranged as a 2 x 2 factorial with 2 planes of nutrition and 2 levels of 
L-arginine supplementation.  Mares received either 0.5% BW (Mod; as fed) or 1% BW 
(High; as fed) per day of a commercial concentrate (Vitality Mare and Foal, Nutrena 
Feeds, Minneapolis, MN).  L-arginine (Ajinomoto AminoScience LLC, Raleigh, NC) 
was fed at 0 or 0.21 g/kgBW/d
 
(Arg) with L-alanine (Ajinomoto AminoScience LLC, 
Raleigh, NC) used to maintain an isonitrogenous diet (Con).   
The NRC (2007) suggests that the daily DE requirement for a 500 kg mare 
during the 11
th
 month gestation  is 21.4 Mcal.  The Mod diets provided an average of 
28.2 Mcal DE/d which is approximately 120% of NRC DE recommendations while High 
diets provided an average of 34.6 Mcal DE/d which is 150% of NRC DE 
recommendations (NRC, 2007).  DE intake was calculated from grain consumption and 
estimated forage intake.   
Dietary treatments began 110 days prior to expected foaling date. Animals were 
fed individually in 3  3 m stalls twice a day at 0615 and 1615.  In pastures, animals had 
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access to ad libitum coastal bermudagrass (Cynodon dactylon) hay and water.  Voluntary 
forage intake was determined using a dual marker system of ADIA and titanium dioxide 
as part of a companion study.  Grain intake was recorded daily.  Table 1 illustrates the 
nutrient composition of the diet components.  After parturition, all mares returned to 
pasture where they were group fed grain mix at approximately 1% of BW (as fed) twice 
daily.  The composition of the lactation grain mix was similar to that used before 
parturition (Table 1).  
 
Table 1. Energy and nutrient composition of concentrate
 
and hay (DM basis) fed to 
mares 
Item Concentrate
1
 Hay
2
 
CP, % 17.76   8.72 
Fat, %  6.96   1.78 
ADF, %  8.30 39.70 
Starch, % 35.30   3.80 
TND, % 80.55 54.91 
Ca, %  0.94  0.44 
P, %  0.83  0.24 
DE, Mcal/kg  1.61  1.10 
1 
Commercial concentrate fed at 0.5% and 1.0% BW (as fed; Vitality Mare and Foal, 
Nutrena Feeds, Minneapolis, MN) 
2 
Hay consisted of coastal bermudagrass (Cynodon dactylon) 
 
 
 
Mare Performance Measurements 
 Mare performance was evaluated on d 0 and every 14 d thereafter until 
parturition with measurements consisting of BW, BCS, and rump fat (RF).  Body weight 
was determined using a GSE 350 electronic scale (Bastrop Scale Co., Inc, Austin, TX) 
and BCS was determined by 3 individual observers on a scale of 1 to 9 (1 is emaciated 
and 9 is morbidly obese) as described by Henneke et al. (1983).  Rump fat was 
determined via ultrasonic images on the left hip at a point 5 cm dorsal of halfway 
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between the first coccygeal vertebra and the ischium (Westervelt et al., 1976), using a 
SSD-500V ultrasound instrument (Aloka Co., LTD, Mitaka-shi, Tokyo, Japan). 
Frequent Sampling IV Glucose Tolerance Test (FSIGT) 
A modified frequent sampling intravenous glucose tolerance test (FSIGT) was 
performed on mares at 11 months gestation (average for the block) and on foals at 5 and 
30 d of age using methods previously described (Hoffman et al., 2003; Winsco et al., 
2011). Prior to the procedure, mares or mares and foals were moved from pasture to 
individual 3  3 m stalls.  The morning feed was withheld. Throughout the FSIGT mares 
had ad libitum access to hay and water, and foals were allowed to nurse.  Nursing times, 
as well as durations, were recorded.  Prior to the FSIGT, animals were weighed using a 
GSE 350 electronic scale (Bastrop Scale Co. Inc., Austin, TX).  The jugular catheter site 
was prepared by clipping the coat to a sanitary length (blade size 50), and sterilized 
using Chloradine scrub 4% in addition to isopropyl alcohol 70%.  Lidocaine was used as 
a local anesthetic and injected subcutaneously at the site of catheter insertion.  Mare 
catheters were 14 G  5.5 inch Abbocath-T Catheter (Abbot Hospitals, North Chicago, 
IL) and foal catheters were 16 G  3.5 inch Angiocath Catheter (BD Medical, Medical 
Surgical Systems, Franklin Lakes, NJ).  Catheters were placed and a 30 inch extension 
set (Hospira, Inc., Lake Forest, IL) was attached to the catheter and secured with 
Elasticon.  Due to the diurnal variation in equine glucose values, the FSIGT was initiated 
at approximately the same time each morning.  Animals were allowed to acclimate for a 
minimum of 1 hr after catheters were placed and prior to sampling.   
After a baseline plasma sample was collected, 0.3 g/kg BW of a glucose bolus 
composed of 50% Dextrose (AGRIpharm, Agripharm Products, Westlake, TX) was 
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administered.  Blood samples were then collected at 1, 2, 3, 4, 5, 6, 7, 8, 10, 12, 14, 16, 
and 19 min.  At minute 20, a 30 mU/kg BW
 
insulin bolus of Humulin (Eli Lilly and 
Company, Indianapolis, IN) was administered.  Since equine insulin is not readily 
available, human insulin is commonly used in equine research as it differs by only two 
amino acids (Kim et al., 2003).  Blood samples collection was continued at 22, 23, 24, 
25, 27, 30, 35, 40, 50, 60, 70, 80, 90, 100, 120, 150, and 180 min.  Samples were placed 
into 10 ml evacuated tubes containing sodium heparin (143 USP units; Becton 
Dickinson, Franklin Lakes, NJ), immediately placed on ice and centrifuged within 20 
min of collection (2,700 x g for 20 min).  Sample plasma was then collected, placed in 
microtubes, and frozen at -20
0
C for later analysis.   
Glucose and Insulin Analysis 
Plasma samples were analyzed for glucose and insulin concentrations. Glucose 
concentrations were determined using a colorimetric assay (Sigma Diagnostics; Glucose 
Procedure No. 510, Charleston, WV).  A glucose enzyme solution was prepared adding 
1 capsule PGO enzyme to 100 mL distilled water in an amber bottle.  Each capsule of 
PGO enzyme contains 500 units of glucose oxidase, 100 purpurogalin units of 
peroxidase and buffer salts.  After inverting the water and enzyme, 1.6 mL of color 
reagent, o-dianisidine dihydrochoride (reconstituted with 20 mL water), was added.  The 
enzyme mixture, PGO enzyme and o-dianisidine dihydrochoride, were stored used 
within 30 d.  All tubes were prepared in duplicate.  A blank was prepared using 0.5 mL 
water.  Standards 1-5 were made using stock -glucose (1mg/mL).  Standard 1 was 
prepared to a 20-fold concentration (0.05 mg/mL), standard 2 a 10-fold concentration 
(0.10 mg/mL), standard 3 a 6.67-fold concentration (0.15 mg/mL), standard 4 a 5-fold 
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concentration (0.20 mg/mL), and standard 5 a 4-fold concentration (0.25 mg/mL).  A 10-
fold dilution was created for the baseline sample in addition samples from min 4 to 180.  
Since glucose concentrations were greatest at sample min 1, 2, and 3, a 20-fold dilution 
was created using reverse osmosis water.  Diluted samples were vortex, 0.25 mL was 
transferred to a separate tube, and 2.5 mL enzyme mixture was added.   All tubes were 
incubated at room temperature (18 to 26 C) for 45 min and then read within 30 min. For 
analysis, dilutions were placed in cuvets and read by a DU 730 Vis Spectrophotometer 
(Beckman Coulter, Inc., Brea, CA) at a wavelength of 450 nm. 
 Insulin concentrations were determined using a commercial radioimmunoassay 
(RIA) kit (Coat-A-Count Insulin, Siemens Healthcare Diagnostics, Tarrytown, NY). 
Polypropylene tubes were labeled in duplicate as T (total counts) and NSB (nonspecific 
binding).  Antibody-coated tubes were labeled A-G in duplicate.  Approximately 200 L 
of zero calibrator A was added into the NSB and A tubes while 200 L of each 
remaining calibrator was added to control tubes.  For mares, 200 L of plasma was 
added in duplicate to coated tubes.  A 5-fold dilution was used in mare samples min 22 
to 27.  For foals, 200 L of plasma from samples 22 to 30 min was used while 2-fold 
concentration was used for min 0 to 19 and 35 to 180.  Within 40 min of placing the first 
sample in coated tubes, 1.0 mL of I-125 insulin was added to every tube and vortex.  
Tubes were left to incubate for 18to 24 hr.  Using a foam decanting rack, tubes (except 
the T tube) were drained and allowed to dry for 2 to 3 min.  Tubes were placed in the 
Packard Cobrat II Gamma Counter (Packard Company, Downers Grove, IL) for 
determination of insulin concentration.   
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Statistical Analysis 
Area under the curve was determined for plasma glucose and insulin according to 
the trapezoidal rule using PROC EXPAND of SAS (SAS Inst., Inc., Cary, NC). 
 All data were analyzed using PROC MIXED of SAS (SAS Inst., Inc., Cary, NC) 
with the model containing effects for plane of nutrition (Nutr), amino acid 
supplementation (AA), and their interactions.  Additionally, with foal data the effect of 
age was included in the model.  Main effects were considered significant when P ≤ 0.05 
and P ≤ 0.10 considered a trend towards significance.  
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CHAPTER III 
RESULTS AND DISCUSSION 
Mare Measurements 
 Mare measurements were not influenced by diet (P ≥ 0.69).  Results specify Mod  
and High least square means.  Body weight ranged from 539.4 to 570.5 kg  18.0, mare 
RF ranged from 0.30 to 0.31 mm  0.007.  Mare BCS ranged from 6.2 to 6.6  0.32 
despite providing 120% (Mod) or 150% (High) of NRC (2007) DE requirements.  
However, it is important to note that all mares, regardless of treatment, were above the 
ideal BCS of 6 (Henneke et al., 1983).  A more detailed evaluation of mare performance 
will be published in a companion paper. 
Mare Glucose and Insulin   
Mare peak glucose (PG) and insulin (PI) concentrations, and the area under the 
curve for glucose (AUCg) and insulin (AUCi) are shown in Table 2.  Mare glucose and 
insulin concentrations in response to the FSIGT are shown in Figure 3.  Mare AUCg, PG, 
and PI concentrations were not influenced by plane of nutritional, AA supplementation, 
or the interaction between nutrition and AA (P ≥ 0.55).  Mare AUCi tended to be 
influenced by the interaction between nutrition and ARG supplementation (P  0.06).  
As expected, HighCon mares had greater (P  0.05) AUCi values compared to those 
offered ModCon.  Additionally, HighArg mares had lower AUCi values compared to 
those offered HighCon (P  0.05). 
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Table 2.  Effect of plane of nutrition and arginine1 (ARG) supplementation on peak  
glucose (PG), peak insulin (PI), glucose area under the curve (AUCg), and insulin   
area under the curve (AUCi)
2
 performed during FSIGT
3 
in the last third of equine gestation 
   Treatment
4
      P-value
5
   
 ModCon ModArg HighCon HighArg    Nutr 
  (n=7) (n=6) (n=7) (n=7) SEM Nutr AA x AA 
PG, mg/mL 375 379 339 364 18 0.18 0.40 0.55 
PI, mU/L 837 733 860 786 153 0.80 0.54 0.92 
AUCg 224 229 220 233 17 0.99 0.55 0.81 
AUCi 9,353 11,193 14,085 9,352 
1,79
2 0.41 0.40 0.06 
1
Ajinomoto (Ajinomoto AminoScience LLC, Raleigh, NC)    
2
Values are in least square means      
3
Frequent sampling I.V. glucose tolerance test (FSIGT)    
4
Grain was fed at 0.5% of BW (as fed) or 1.0% of BW (as fed) and ARG was supplemented 
 at 0 (Ala) or 0.21g/kg/day (Arg) resulting in 4 treatments ModCon = 0.5% BW (as fed) +  
Ala, ModArg = 0.5% BW (as fed) + Arg, HighCon = 1.0% BW (as fed) + Ala, and HighArg  
= 1.0% BW (as fed) + Arg       
5
Nutr = effect of nutrition, AA = effect of amino acid, and nutr and AA = interaction 
between nutr and AA        
 
 
 
Winsco et al. (2011) observed greater mare AUCg when horses were 
supplemented with grain as compared to mares fed forage alone.  However, in the 
current study, all mares received grain supplementation, which may have altered the 
AUCg values compared to those obtained with mares fed forage alone.  Mare PG 
concentrations were similar to those observed by previous research (Hoffman et al., 
2003a; Winsco et al, 2011).  Their results concluded that nutritional plane and BCS had 
little effect on PG concentrations during an FSIGT.   
With respect to mare AUCi, ModCon mares had lower concentrations than 
HighCon, which supports previous findings that feeding high grain diets during the last 
third of pregnancy in mares can alter insulin production or sensitivity (Winsco et al., 
2011).  Hoffman et al. (2003b) found conflicting results as mares in their study fed diets 
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high in starch and sugar (SS) had lower AUCi than those fed isocaloric diets high in fat 
and fiber (FF) in late pregnancy.  They concluded that mares fed SS did not produce as 
much insulin as FF mares, which could be associated with adaptation to grain 
supplementation as mares were fed in both early and late gestation.  
 
a) 
 
Figure 3. Effects of nutrition and ARG supplementation on mare glucose and insulin during modified 
FSIGT in the last third of pregnancy.  Mare dietary treatments: a) Grain 0.5% BW (as fed) + Alanine 
(ModCon; n = 7) b) Grain 0.5% BW (as fed) + Arg (ModArg; n = 6) c) Grain 1.0% BW (as fed) + Alanine 
(HighCon; n = 7) d) Grain 1.0% BW (as fed) + Arg (HighArg; n = 7). Least square means are reported. 
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b)
 
c)  
 
Figure 3 Continued. 
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d) 
 Figure 3 Continued. 
 
 
 
In addition, our results concluded HighCon mares had greater AUCi than 
HighArg mares (P  0.05).  This demonstrates the potential for ARG supplementation to 
mitigate the effects of high starch diets in the horse.  Human research has shown ARG 
supplementation can improve insulin sensitivity in diabetic patients (Piatti et. Al., 2001). 
As insulin sensitivity is stimulated, less insulin is needed to initiate regulation of blood 
glucose.  While research with ARG supplementation has determined it can increase 
pancreatic insulin response in sheep and rats (Fajans et al., 1967), further information 
regarding ARG supplementation is needed in the horse to determine the approximate 
mode of action.   
Foal Glucose and Insulin 
Foal PG, PI, AUCg, and AUCi for d 5 and d 30 are shown in Table 3.  Foal 
glucose and insulin dynamics evaluated on d 5 and d 30 are shown in Figures 4 and 5, 
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respectively.  Foal PG (d 5 and d 30 combined) tended to be influenced by maternal AA 
supplementation (P  0.09) with foals from Con mares having greater PG concentration 
than foals from Arg mares (275  6.5 and 260  5.2 mg/dL, respectively).  
 
Table 3.  Effect of plane of nutrition and arginine
1
 (ARG) supplementation on
 
peak glucose 
(PG), peak insulin (PI), glucose area under the curve (AUCg), and insulin area under the 
curve (AUCi)
2
 performed during FSIGT
3
 on foals at d 5 and d 30 of age.     
       Treatment
4
      P-value
5
   
 ModCon ModArg HighCon HighArg    Nutr  
  (n = 4) (n = 8) (n = 8) (n = 8) SEM Nutr AA x AA Age 
PG, mg/dl      0.34 0.09 0.67 0.94 
d 5   281 264 264 259 12     
d 30 273 268 281 250 17     
PI, mU/L      0.53 0.24 0.62 0.80 
d 5   264 258 163 223 68     
d 30 202 267 207 292 78     
AUCg      0.79 0.38 0.31 
  
<0.01 
d 5   274 283 299 285 25     
d 30 260 255 271 233 19     
AUCi      0.48 0.49 0.22 0.08 
d 5   2,466 2,886 2,515 3,313 1,232     
d 30 5,865 2,720 3,165 12,057 5,249         
1
Ajinomoto (Ajinomoto AminoScience LLC, Raleigh, NC)     
2
Values are least square means       
3
 Frequent sampling I.V. glucose tolerance test (FSIGT)     
4
Grain was fed to mares at 0.5% of BW (as fed) or 1.0% of BW (as fed) and ARG was supplemented 
at  0 (Ala) or 0.21g/kg/day (Arg) resulting in 4 treatments ModCon = 0.5%  BW (as fed) + Ala, 
ModArg = 0.5% BW (as fed) + Arg, HighCon = 1.0% BW (as fed) + Ala, and HighArg = 1.0% BW 
(as fed) + Arg 
5
Nutr. = effect of nutrition, AA = effect of amino acid, Nutr. And AA = interaction between nutrition 
and AA, and Age = effect of age.  P-values represent combined (d 5 and d 30) data for all main 
effects except age 
 
 
 
While foal PI was not influenced by nutritional plane, AA supplementation, age, 
or the interaction between (P > 0.24), foal AUCg was influenced by age, regardless of 
maternal diet, with d 5 foals having greater AUCg than d 30 foals (P  0.003).  In 
addition, foal AUCi tended to be influenced by age, as AUCi was greater in d 30 foals 
than in d 5 foals (P  0.08). 
30 
 
a) 
 
b) 
 
Figure 4. Effects of maternal nutrition and ARG supplementation on foal d 5 glucose and insulin during 
modified FSIGT.  Mare dietary treatments: a) Grain 0.5% BW (as fed) + Alanine (ModCon; n = 7) b) 
Grain 0.5% BW (as fed) + Arg (ModArg; n = 6) c) Grain 1.0% BW (as fed) + Alanine (HighCon; n = 7) d) 
Grain 1.0% BW (as fed) + Arg (HighArg; n = 7). Least square means are reported. 
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c)  
d) 
Figure 4 Continued. 
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a) 
 
b) 
 
Figure 5. Effects of maternal nutrition and ARG supplementation on foal d 30 glucose and insulin during 
modified FSIGT.  Mare dietary treatments: a) Grain 0.5% BW (as fed) + Alanine (ModCon; n = 7) b) 
Grain 0.5% BW (as fed) + Arg (ModArg; n = 6) c) Grain 1.0% BW (as fed) + Alanine (HighCon; n = 7) d) 
Grain 1.0% BW (as fed) + Arg (HighArg; n = 7). Least square means are reported. 
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c) 
 
d) 
 
Figure 5 Continued. 
 
In the current study, foal AUCg decreased and AUCi increased from 5 to 30 d of 
age.  Previous research has shown the fetal pancreas becomes increasingly responsive to 
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glucose during late gestation with greater amounts of insulin production in preparation 
for postnatal glucose homeostasis (Fowden et al., 2005). Once the foal is born, decreased 
pancreatic activity is observed on the first day of life and progressively increases in the 
ability to produce insulin for at least 10 d (Holdstock et al., 2004).  While these results 
conflict with previous findings of decreasing insulin concentrations observed in FSIGT 
performed on foals at 80 and 160 d of age (Winsco et al., 2011), the differences might 
simply be due to the age of the foals and difference in management across trials.  Older 
foals consume higher percentages of DM, in the form of concentrate and forage, which 
may alter metabolism and provide variable results compared to younger foals consuming 
primarily milk.   Diet and development of foal metabolism could also attributed to the 
differences between foal and mare glucose and insulin concentrations.  FSIGT resulted 
in lower foal concentrations as compared to mares.  
Within the data, there were foals with increased insulin concentrations post 
insulin bolus.  In HighArg d 30 foal insulin concentrations the rise in concentrations can 
be easily seen as additional peaks around min 35, 70 and 120.  These additional peaks 
coincide with a decrease in glucose concentrations.  An explanation for these findings 
remains unclear.   
Minimal research in the horse has looked specifically at foal glucose and insulin 
dynamics, especially relative to maternal nutrition. Additionally, current research differs 
greatly in experimental design,  data collection and analysis, and animal management.  
Differences in maternal nutrition, foal sampling age, foal sample times and foal sample 
methods make comparisons difficult.  Winsco et al. (2011) found foals from mares 
supplemented with grain had greater insulin concentrations compared to foals from 
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mares fed forage only, suggesting maternal grain supplementation decreased offspring 
insulin sensitivity (SI).  George et al. (2009) found foals from mares fed low starch diets 
had greater glucose clearance and insulin sensitivity as compared to foals from mares fed 
high starch diets.  In the current study, all mares received grain supplementation, and a 
difference in foal SI relative to nutritional plane was not observed.  The significance of 
this study is the observation of a decrease in peak glucose, which could potentially 
indicate an increase in SI of foals from mares supplemented with ARG.  After the 
endogenous administration of glucose, foals from ARG mares had lower peak glucose 
concentrations than foals from Con mares.   
Studies in other species, such as the rat, suggest animals exposed to 
hyperglycemia as a developing fetus, develop impaired glucose tolerance and insulin 
secretion (Gauguier et al., 1991).  In addition, fetal IUGR can alter glucose metabolism 
during gestation, lead to type 2 diabetes in adult offspring (Simmons et al., 2001) and 
alter GLUT 4 protein levels (Boloker et al., 2002).  Rats from diabetic mothers also 
demonstrated decreased NO production.  Supplementation of ARG has been seen to 
reduce IUGR in the fetus (Xiao and Li, 2005) and increase NO production in offspring at 
later stages (Cauanal et al., 2007).  While this data is promising, it is difficult to make 
comparisons across species due to differences in gestational length, fetal growth 
patterns, and placenta type.  Ovine research has shown similar results as ARG 
supplementation improved fetal growth and development (Wu et al., 2007) and porcine 
research has shown ARG supplementation increases reproduction and fetal survival rate  
(Mateo et al., 2007).  In other species,  the ARG stimulated production of NO appears to 
be a significant mechanism.  Although NO production was not directly measured in the 
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current study, the increase in NO produced by ARG supplementation could potentially 
mitigate the effects of over maternal nutrition on mare and fetal metabolism.  
Continued research is needed to look at long term effects of maternal nutrition on 
foal metabolism, and to more thoroughly evaluate the effect of arginine supplementation 
on the mare and foal.  In sheep, ewes fed nutritional planes similar (150% NRC)  to the 
current study resulted in altered mature offspring glucose and insulin metabolism and 
adipose tissue (Long et al., 2010).  In the current study, maternal BW did not 
significantly increase, but nutritional effect on metabolism was observed which suggest 
metabolic changes may occur without obesity.  Long et al. (2010) observed a 52% 
increase in BW of obese sheep.  Long term effects evaluated offspring of obese sheep.  
Offspring consumed greater amounts of feed, gained greater amounts of BW and body 
fat, and demonstrated decreased insulin response and glucose effectiveness during 
FSIGT as compared to control lambs.  
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CHAPTER IV 
CONCLUSIONS 
In conclusion, maternal nutritional plane and ARG supplementation did alter 
mare and foal metabolism.  Results indicated mitigation of increased nutritional plane 
through ARG supplementation on glucose and insulin dynamics in the reproductive 
horse. This is the first study to evaluate effects of ARG supplementation in the horse and 
on fetal programming.  Additionally, this study provided valuable information on 
maternal nutrition and its influence on fetal metabolism, and age related effects on foal 
metabolism.  While further research is needed to determine the direct mechanism and 
effect of ARG supplementation, results indicate there is an ability of ARG 
supplementation to increase insulin sensitivity in the horse.   
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